カテゴリー： Market Monitor Global, 世界, 医療/バイオ

OTC医薬品の世界市場見通し2023年-2029年

◆英語タイトル：OTC Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2498）

◆商品コード：MMG23FB2498
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：113
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のOTC医薬品市場規模と予測を収録しています。・世界のOTC医薬品市場：売上、2018年-2023年、2024年-2029年
・世界のOTC医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のOTC医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「消化器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

OTC医薬品のグローバル主要企業は、Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euraditeなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、OTC医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のOTC医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界のOTC医薬品市場：タイプ別市場シェア、2022年
・消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他

世界のOTC医薬品市場：用途別、2018年-2023年、2024年-2029年
世界のOTC医薬品市場：用途別市場シェア、2022年
・薬局、病院薬局、ネット通販、その他

世界のOTC医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界のOTC医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるOTC医薬品のグローバル売上、2018年-2023年
・主要企業におけるOTC医薬品のグローバル売上シェア、2022年
・主要企業におけるOTC医薬品のグローバル販売量、2018年-2023年
・主要企業におけるOTC医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite

*************************************************************

・調査・分析レポートの概要
OTC医薬品市場の定義
市場セグメント
世界のOTC医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のOTC医薬品市場規模
世界のOTC医薬品市場規模：2022年 VS 2029年
世界のOTC医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのOTC医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のOTC医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：消化器、皮膚科、耳鼻咽喉科、栄養・ビタミン、その他
OTC医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、病院薬局、ネット通販、その他
OTC医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別OTC医薬品市場規模 2022年と2029年
地域別OTC医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite
...

This report aims to provide a comprehensive presentation of the global market for OTC Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Medicine. This report contains market size and forecasts of OTC Medicine in global, including the following market information:
Global OTC Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global OTC Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gastrointestinal Tract Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of OTC Medicine include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer, Aktienge, Sanofi and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OTC Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global OTC Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global OTC Medicine Market Segment Percentages, by Type, 2022 (%)
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others
Global OTC Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global OTC Medicine Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital Pharmacy
Online Retailer
Others
Global OTC Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global OTC Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies OTC Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC Medicine, market overview.
Chapter 2: Global OTC Medicine market size in revenue.
Chapter 3: Detailed analysis of OTC Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 OTC Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global OTC Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC Medicine Overall Market Size
2.1 Global OTC Medicine Market Size: 2022 VS 2029
2.2 Global OTC Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top OTC Medicine Players in Global Market
3.2 Top Global OTC Medicine Companies Ranked by Revenue
3.3 Global OTC Medicine Revenue by Companies
3.4 Top 3 and Top 5 OTC Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies OTC Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 OTC Medicine Players in Global Market
3.6.1 List of Global Tier 1 OTC Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 OTC Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global OTC Medicine Market Size Markets, 2022 & 2029
4.1.2 Gastrointestinal Tract
4.1.3 Dermatology
4.1.4 Otolaryngology
4.1.5 Nutrition/Vitamins
4.1.6 Others
4.2 By Type – Global OTC Medicine Revenue & Forecasts
4.2.1 By Type – Global OTC Medicine Revenue, 2018-2023
4.2.2 By Type – Global OTC Medicine Revenue, 2024-2029
4.2.3 By Type – Global OTC Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global OTC Medicine Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital Pharmacy
5.1.4 Online Retailer
5.1.5 Others
5.2 By Application – Global OTC Medicine Revenue & Forecasts
5.2.1 By Application – Global OTC Medicine Revenue, 2018-2023
5.2.2 By Application – Global OTC Medicine Revenue, 2024-2029
5.2.3 By Application – Global OTC Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global OTC Medicine Market Size, 2022 & 2029
6.2 By Region – Global OTC Medicine Revenue & Forecasts
6.2.1 By Region – Global OTC Medicine Revenue, 2018-2023
6.2.2 By Region – Global OTC Medicine Revenue, 2024-2029
6.2.3 By Region – Global OTC Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America OTC Medicine Revenue, 2018-2029
6.3.2 US OTC Medicine Market Size, 2018-2029
6.3.3 Canada OTC Medicine Market Size, 2018-2029
6.3.4 Mexico OTC Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe OTC Medicine Revenue, 2018-2029
6.4.2 Germany OTC Medicine Market Size, 2018-2029
6.4.3 France OTC Medicine Market Size, 2018-2029
6.4.4 U.K. OTC Medicine Market Size, 2018-2029
6.4.5 Italy OTC Medicine Market Size, 2018-2029
6.4.6 Russia OTC Medicine Market Size, 2018-2029
6.4.7 Nordic Countries OTC Medicine Market Size, 2018-2029
6.4.8 Benelux OTC Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia OTC Medicine Revenue, 2018-2029
6.5.2 China OTC Medicine Market Size, 2018-2029
6.5.3 Japan OTC Medicine Market Size, 2018-2029
6.5.4 South Korea OTC Medicine Market Size, 2018-2029
6.5.5 Southeast Asia OTC Medicine Market Size, 2018-2029
6.5.6 India OTC Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America OTC Medicine Revenue, 2018-2029
6.6.2 Brazil OTC Medicine Market Size, 2018-2029
6.6.3 Argentina OTC Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa OTC Medicine Revenue, 2018-2029
6.7.2 Turkey OTC Medicine Market Size, 2018-2029
6.7.3 Israel OTC Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia OTC Medicine Market Size, 2018-2029
6.7.5 UAE OTC Medicine Market Size, 2018-2029
7 OTC Medicine Companies Profiles
7.1 Procter & Gamble
7.1.1 Procter & Gamble Company Summary
7.1.2 Procter & Gamble Business Overview
7.1.3 Procter & Gamble OTC Medicine Major Product Offerings
7.1.4 Procter & Gamble OTC Medicine Revenue in Global Market (2018-2023)
7.1.5 Procter & Gamble Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson OTC Medicine Major Product Offerings
7.2.4 Johnson & Johnson OTC Medicine Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Company Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc OTC Medicine Major Product Offerings
7.3.4 GlaxoSmithKline Plc OTC Medicine Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Plc Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories OTC Medicine Major Product Offerings
7.4.4 Abbott Laboratories OTC Medicine Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Amway Corporation
7.5.1 Amway Corporation Company Summary
7.5.2 Amway Corporation Business Overview
7.5.3 Amway Corporation OTC Medicine Major Product Offerings
7.5.4 Amway Corporation OTC Medicine Revenue in Global Market (2018-2023)
7.5.5 Amway Corporation Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer OTC Medicine Major Product Offerings
7.6.4 Bayer OTC Medicine Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Aktienge
7.7.1 Aktienge Company Summary
7.7.2 Aktienge Business Overview
7.7.3 Aktienge OTC Medicine Major Product Offerings
7.7.4 Aktienge OTC Medicine Revenue in Global Market (2018-2023)
7.7.5 Aktienge Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi OTC Medicine Major Product Offerings
7.8.4 Sanofi OTC Medicine Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer OTC Medicine Major Product Offerings
7.9.4 Pfizer OTC Medicine Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Reckitt Benckiser Group
7.10.1 Reckitt Benckiser Group Company Summary
7.10.2 Reckitt Benckiser Group Business Overview
7.10.3 Reckitt Benckiser Group OTC Medicine Major Product Offerings
7.10.4 Reckitt Benckiser Group OTC Medicine Revenue in Global Market (2018-2023)
7.10.5 Reckitt Benckiser Group Key News & Latest Developments
7.11 Church & Dwight
7.11.1 Church & Dwight Company Summary
7.11.2 Church & Dwight Business Overview
7.11.3 Church & Dwight OTC Medicine Major Product Offerings
7.11.4 Church & Dwight OTC Medicine Revenue in Global Market (2018-2023)
7.11.5 Church & Dwight Key News & Latest Developments
7.12 Bayer HealthCare
7.12.1 Bayer HealthCare Company Summary
7.12.2 Bayer HealthCare Business Overview
7.12.3 Bayer HealthCare OTC Medicine Major Product Offerings
7.12.4 Bayer HealthCare OTC Medicine Revenue in Global Market (2018-2023)
7.12.5 Bayer HealthCare Key News & Latest Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Company Summary
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca OTC Medicine Major Product Offerings
7.13.4 AstraZeneca OTC Medicine Revenue in Global Market (2018-2023)
7.13.5 AstraZeneca Key News & Latest Developments
7.14 BioGaia
7.14.1 BioGaia Company Summary
7.14.2 BioGaia Business Overview
7.14.3 BioGaia OTC Medicine Major Product Offerings
7.14.4 BioGaia OTC Medicine Revenue in Global Market (2018-2023)
7.14.5 BioGaia Key News & Latest Developments
7.15 Bristol Myers Squibb
7.15.1 Bristol Myers Squibb Company Summary
7.15.2 Bristol Myers Squibb Business Overview
7.15.3 Bristol Myers Squibb OTC Medicine Major Product Offerings
7.15.4 Bristol Myers Squibb OTC Medicine Revenue in Global Market (2018-2023)
7.15.5 Bristol Myers Squibb Key News & Latest Developments
7.16 Chr. Hansen
7.16.1 Chr. Hansen Company Summary
7.16.2 Chr. Hansen Business Overview
7.16.3 Chr. Hansen OTC Medicine Major Product Offerings
7.16.4 Chr. Hansen OTC Medicine Revenue in Global Market (2018-2023)
7.16.5 Chr. Hansen Key News & Latest Developments
7.17 Cipla
7.17.1 Cipla Company Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla OTC Medicine Major Product Offerings
7.17.4 Cipla OTC Medicine Revenue in Global Market (2018-2023)
7.17.5 Cipla Key News & Latest Developments
7.18 CoLucid
7.18.1 CoLucid Company Summary
7.18.2 CoLucid Business Overview
7.18.3 CoLucid OTC Medicine Major Product Offerings
7.18.4 CoLucid OTC Medicine Revenue in Global Market (2018-2023)
7.18.5 CoLucid Key News & Latest Developments
7.19 Daiichi Sankyo
7.19.1 Daiichi Sankyo Company Summary
7.19.2 Daiichi Sankyo Business Overview
7.19.3 Daiichi Sankyo OTC Medicine Major Product Offerings
7.19.4 Daiichi Sankyo OTC Medicine Revenue in Global Market (2018-2023)
7.19.5 Daiichi Sankyo Key News & Latest Developments
7.20 Friggs
7.20.1 Friggs Company Summary
7.20.2 Friggs Business Overview
7.20.3 Friggs OTC Medicine Major Product Offerings
7.20.4 Friggs OTC Medicine Revenue in Global Market (2018-2023)
7.20.5 Friggs Key News & Latest Developments
7.21 DSM
7.21.1 DSM Company Summary
7.21.2 DSM Business Overview
7.21.3 DSM OTC Medicine Major Product Offerings
7.21.4 DSM OTC Medicine Revenue in Global Market (2018-2023)
7.21.5 DSM Key News & Latest Developments
7.22 Eisai
7.22.1 Eisai Company Summary
7.22.2 Eisai Business Overview
7.22.3 Eisai OTC Medicine Major Product Offerings
7.22.4 Eisai OTC Medicine Revenue in Global Market (2018-2023)
7.22.5 Eisai Key News & Latest Developments
7.23 Eli Lilly
7.23.1 Eli Lilly Company Summary
7.23.2 Eli Lilly Business Overview
7.23.3 Eli Lilly OTC Medicine Major Product Offerings
7.23.4 Eli Lilly OTC Medicine Revenue in Global Market (2018-2023)
7.23.5 Eli Lilly Key News & Latest Developments
7.24 Herbalife
7.24.1 Herbalife Company Summary
7.24.2 Herbalife Business Overview
7.24.3 Herbalife OTC Medicine Major Product Offerings
7.24.4 Herbalife OTC Medicine Revenue in Global Market (2018-2023)
7.24.5 Herbalife Key News & Latest Developments
7.25 Euradite
7.25.1 Euradite Company Summary
7.25.2 Euradite Business Overview
7.25.3 Euradite OTC Medicine Major Product Offerings
7.25.4 Euradite OTC Medicine Revenue in Global Market (2018-2023)
7.25.5 Euradite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ OTC医薬品の世界市場見通し2023年-2029年(OTC Medicine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

OTC医薬品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp